Combined with ultrasound therapy, the HB-NLG8189@MPCM group significantly elevated Th cell and CTL populations in tumors while suppressing IDO-1 activation and modulating regulatory T cell infiltration, thereby reversing the immunosuppressive tumor microenvironment. The gene discussed is IDO1; the disease is neoplasm.